Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer (STRIVE)

STRIVE: A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide vs. Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy

Category & Conditions:
Cancer
Medicine:
Xtandi (enzalutamide)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
C3431014
Open Plain Language Summary Result:Click here